:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
   
  TM4SF5 accelerates G1/S phase progression via cytosolic p27(Kip1) expression and RhoA activity.
  ±Û¾´ÀÌ : ÃÖ°í°ü¸®ÀÚ     ³¯Â¥ : 10-08-05 13:37     Á¶È¸ : 1606    
   2010-17.pdf (1.3M), Down : 7, 2010-08-05 13:37:15
Hyeonjung Kim a, Minkyung Kang b, Sin-Ae Lee c, Tae Kyoung Kwak a, Oisun Jung e, Hyo Jeong Lee f,
Sung-Hoon Kim f, Jung Weon Lee a,d,e,⁎
a Department of Tumor Biology, Cancer Research Institute, Cell Dynamics Research Center, College of Medicine, Seoul National University, Seoul 151-742, Republic of Korea
b Department Biomedical Sciences, Cancer Research Institute, Cell Dynamics Research Center, College of Medicine, Seoul National University, Seoul 151-742, Republic of Korea
c Department Molecular and Clinical Oncology, Cancer Research Institute, Cell Dynamics Research Center, College of Medicine, Seoul National University, Seoul 151-742, Republic of Korea
d Department of Pharmacy, Cell Dynamics Research Center, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea
e Genetic Engineering, Seoul National University, Seoul 151-742, Republic of Korea
f CPMDRC, Kyunghee University, Seoul 131-701, Republic of Korea

Biochimica et Biophysica Acta

   

:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::